Methadone does help with pain, and it has been used as a painkiller since 1947, decades before it became widely known as an addiction treatment. It works differently from most opioid painkillers, which gives it advantages for certain types of pain that don’t respond well to standard medications. In studies of patients whose pain resisted other opioids, about 71% experienced a significant drop in pain scores after switching to methadone.
Why Methadone Works Differently Than Other Opioids
Most opioid painkillers work by binding to a single type of receptor in the brain and spinal cord. Methadone does this too, but it also blocks a second receptor involved in a process called “wind-up,” where the nervous system becomes increasingly sensitive to pain signals over time. This dual action makes methadone effective against two distinct categories of pain: the standard tissue-damage pain you feel from an injury or tumor, and nerve pain, which involves damaged or misfiring nerves sending false signals.
That second mechanism is what sets methadone apart. Nerve pain, the burning, shooting, or tingling kind, is notoriously difficult to treat with conventional opioids. In a trial of 18 patients with nerve pain, 100% of those with shooting pain had complete resolution, and 70% of those with a type of pain triggered by light touch saw it disappear entirely. A separate review of 13 patients with nerve pain that had resisted conventional painkillers found methadone relieved pain and improved sleep in 62% of cases.
Conditions It Treats
Methadone is used for chronic pain from a range of conditions, with the strongest evidence in three areas: cancer pain, nerve pain, and pain that hasn’t responded to other opioids.
For cancer pain, a review of ten studies found methadone performed as well as other strong opioids, including fentanyl, while also reducing a phenomenon called hyperalgesia, where opioid use itself makes the body more sensitive to pain over time. This is a real problem for cancer patients on long-term opioid therapy, and methadone’s ability to counteract it makes it a practical choice when other options start losing effectiveness.
For patients stuck in a cycle of escalating doses and diminishing returns from other opioids, methadone often serves as a reset. In a 2022 study of 90 patients with pain that persisted despite multiple prior opioid treatments, switching to methadone reduced both overall pain scores and the frequency of breakthrough pain episodes in 71% of patients. When compared head-to-head with morphine for nerve pain, patients reported similar reductions in pain intensity, but those on methadone reported higher satisfaction and a stronger sense that their condition had improved.
How It’s Taken for Pain
For pain management, methadone is typically taken by mouth every eight hours. A single dose provides pain relief for roughly four to eight hours. For someone who has never taken opioids before, the starting dose is low, around 2.5 mg three times daily, with increases made no more often than every five to seven days. Older or frail patients sometimes start at just 2.5 mg once per day.
Patients already taking another opioid don’t simply swap over at an equivalent dose. The conversion from other opioids to methadone is not a simple ratio. At low doses, the relationship is roughly 10 mg of morphine to 1 mg of methadone. But at higher doses, methadone becomes proportionally more potent, so the ratio shifts dramatically. This non-linear math is one reason methadone for pain is typically managed by providers with specific experience in opioid prescribing.
How to Get It
There’s a common misconception that methadone is only available through specialized clinics. That restriction applies only to methadone dispensed for opioid addiction. When prescribed for pain, methadone can be filled at any retail pharmacy, just like other Schedule II controlled substances. Any provider with the authority to prescribe controlled medications can write a prescription for methadone as a painkiller. This distinction has been in place since 1976, when federal courts ruled that the FDA could not restrict pharmacy access for the drug’s analgesic use.
Serious Risks Worth Understanding
Methadone carries risks that are meaningfully different from other opioid painkillers, and those risks stem from a single quirk: the drug stays active in your body far longer than its pain relief lasts. You feel relief for four to eight hours, but methadone’s elimination half-life ranges from 5 to 59 hours depending on the individual. In people who metabolize the drug slowly, it can accumulate with repeated doses, building to dangerous levels before anyone realizes there’s a problem.
This mismatch between pain relief and drug activity is the main reason methadone-related deaths occur. The peak respiratory depressant effect, meaning the point at which the drug most strongly suppresses your drive to breathe, hits later and lasts longer than the peak painkilling effect. The highest-risk period is during the first days and weeks of treatment, when the drug is still building up in your system and neither you nor your provider has a clear picture of how quickly your body clears it. The wide individual variation in metabolism appears to be driven by genetic differences in a specific liver enzyme system.
Heart Rhythm Changes
Methadone can also affect the electrical timing of your heartbeat, a condition measured by something called the QTc interval on an EKG. Prolongation of this interval increases the risk of a dangerous heart rhythm called Torsades de pointes. While most reported cases involve patients on high doses for pain, it has also occurred at standard doses. Baseline EKG monitoring is recommended before starting methadone, with a follow-up within 30 days. If the QTc interval exceeds 500 milliseconds, providers generally reduce the dose or switch to a different medication.
Who It’s Best Suited For
Methadone is not a first-line painkiller for most people. Its role is most clear in situations where other approaches have fallen short: cancer pain that’s escalating despite dose increases, chronic nerve pain that hasn’t responded to standard treatments, or cases where a patient needs to rotate off another opioid due to side effects or diminishing relief. Its low cost compared to many extended-release opioid formulations also makes it a practical option when finances are a barrier to pain management.
The combination of potent pain relief and serious safety concerns means methadone for pain requires more careful monitoring than most alternatives, particularly in the first few weeks. But for the right patient and the right type of pain, the evidence supports it as one of the more effective tools available.